Free Newsletter
Merck plans copy of Rotateq in India
MSD Wellcome Trust Hilleman Laboratories, set up in India last year with support from Merck, will attempt to make a copy of the company's Rotateq vaccine for the prevention of diarrhea. Researchers there want to create a copycat that doesn't require refrigeration, making it more accessible to developing nations. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
More Research Reports >>
SHARE
WITH: